Status:
ENROLLING_BY_INVITATION
Personalised Treatment for OSA
Lead Sponsor:
University Hospital, Antwerp
Conditions:
Sleep Apnea Syndrome (OSAS)
Sleep Apnea Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Obstructive sleep apnea (OSA) is a sleep disorder characterized by repetitive episodes of partial or complete obstruction of the upper airway during sleep. Continuous positive airway pressure (CPAP) i...
Detailed Description
Obstructive sleep apnea (OSA) is a sleep disorder characterized by repetitive episodes of partial or complete obstruction of the upper airway during sleep, leading to reduced or completely stopped air...
Eligibility Criteria
Inclusion
- adult patients (age starting from 18 years old)
- moderate to severe OSA (AHI ≥ 15/h)
- CPAP-intolerant or non-compliant
- willing to explore alternative treatment options
Exclusion
- patients who are still on CPAP therapy
- pediatric patients
- newly diagnosed patients who have not had CPAP before
- patients with AHI ≥ 65 events/h.
Key Trial Info
Start Date :
April 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT06915077
Start Date
April 28 2025
End Date
January 1 2030
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universiteit Antwerpen
Wilrijk, Antwerpen, Belgium, 2610